Taro Corporate
Taro U.S.A
Taro Canada
Taro Israel
Sun Pharma
Chattem Chemicals Inc.
Taro RX product details
Product Information
-
DIN:02492571
-
Active Ingredients :ticagrelor
-
Innovator Name:BRILINTA ®
-
Category:Platelet Aggregation Inhibitor
-
Dosage form:Tablet
-
Strength:60 mg
-
Route of Administration:Oral
- Package size:
60 Blister 60 Bottle - UPC Code:
063691085497 063691085466 -
Description :Taro-Ticagrelor is available as 60 mg pink, round film coated tablets with “T T 6” engraved on one side and plain on the reverse side.
-
Non-medicinal ingredients :Croscarmellose sodium, hydroxypropyl cellulose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and film coating [hypromellose 2910, polyethylene glycol 400, talc, titanium dioxide, ferric oxide black (60 mg), ferric oxide red (60 mg), ferric oxide yellow (90 mg)].
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here
Product Information
-
DIN:02492598
-
Active Ingredients :ticagrelor
-
Innovator Name:BRILINTA ®
-
Category:Platelet Aggregation Inhibitor
-
Dosage form:Tablet
-
Strength:90 mg
-
Route of Administration:Oral
- Package size:
60 Blister 60 Bottle - UPC Code:
063691085220 063691085244 -
Description :Taro-Ticagrelor is available as 90 mg yellow, round film coated tablets with “T T” engraved on one side and plain on the other side.
-
Non-medicinal ingredients :Croscarmellose sodium, hydroxypropyl cellulose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and film coating [hypromellose 2910, polyethylene glycol 400, talc, titanium dioxide, ferric oxide black (60 mg), ferric oxide red (60 mg), ferric oxide yellow (90 mg)].
All brand names and trademarks referenced remain the property of their respective owners.
To view the available Product Monographs for Taro Pharmaceuticals Inc. and TaroPharma products please click here to access the Health Canada Drug Product Database and search by DIN or other listed criteria. You may also contact us to request the information.
For Provincial Formulary Status click here